BackZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) Overview

ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) Inventory

Track ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War)'s inventory ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$0.00

Peer average

Loading

ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) Inventory History

Loading

ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) vs. peers: Inventory Comparison

Loading

ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) (LSPRU) FAQ

The latest inventory for LSPRU is $0 as of March 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, LSPRU's inventory moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War)'s operating scale or balance-sheet position.

A inventory figure of $0 for LSPRU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting LSPRU's inventory ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.